ESC 365 - Medical treatment or surgical revascularisation in HF of ischaemic aetiology?

HFA Premium Access

Medical treatment or surgical revascularisation in HF of ischaemic aetiology?

Session: Heart failure and coronary artery disease: medicate? dilate? or operate?

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Speaker: Doctor J. Bartunek (Aalst, BE)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jozef Bartunek

Olv Hospital Aalst, Aalst (Belgium)

4 presentations

0 follower

3 more presentations in this session

Why is CAD underdiagnosed in ADHF patients?

Speaker: Professor H. Skouri (Beirut, LB)

When is percutaneous approach the ideal therapeutic strategy?

Speaker: Professor M. Petrie (Glasgow, GB)

Heart failure and coronary artery disease: medicate? dilate? or operate? - discussion

Access the full session

Heart failure and coronary artery disease: medicate? dilate? or operate?

Speakers: Doctor J. Bartunek, Professor H. Skouri, Professor M. Petrie

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources